Risk factor
Very high price volatility
Profitability factor
Solid dividends
About
Oriola Oyj, headquartered in Espoo, Finland, and established in 1907, is a leading player in the wholesale distribution of pharmaceuticals and a wide array of health and wellness products across Sweden, Finland, and international markets. Their extensive product portfolio includes vitamins, nutritional supplements, sports-specific items, wound care solutions, beauty and cosmetic goods, vaccines, and over-the-counter medications. Beyond distribution, Oriola provides a comprehensive suite of expert services. These encompass pharmaceutical logistics, specialized import of licensed medicines, personalized dose dispensing, and support for research pharmacies. The company also offers commercial data insights, clinical trial management, regulatory affairs, quality assurance, medical and scientific advisory, market access strategies, real-world evidence generation, sales support, medical translation, pharmacovigilance, medical information, and patient assistance programs, alongside general advisory services. Oriola serves a diverse client base, ranging from pharmaceutical manufacturers and pharmacies to veterinarians, hospitals, healthcare providers, specialty stores, retailers, and e-commerce businesses.
Company Valuation
Based on key historical and expected multiples, the stock is fairly valued relative to its peers.
Target Price
The average target price of OKDBV.HE is 1.2 and suggests 13% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendati